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Abstract: 
The characteristics of epigenetic control including the potential for long lasting, stable 
effects on gene expression that outlive an initial transient signal, could be of singular 
importance for post-mitotic neurons, which are subject to changes with short to long 
lasting influence on their activity and connectivity. Persistent changes in chromatin 
structure are thought to contribute to mechanisms of epigenetic inheritance. Recent 
advances in chromatin biology offer new avenues to investigate regulatory mechanisms 
underlying long-lasting changes in neurons, with direct implications for the study of brain 
function, behavior and diseases. 
 
Introduction: 
One of the most intriguing and fundamental properties of brain function is the ability to 
sustain long-term changes in patterns of neuronal activity, a phenomenon broadly defined 
as memory. Memory lasts minutes to years 1 underscoring the existence of multiple 
strategies that afford neurons with short- to long-lasting functional changes. Precise 
mechanisms underlying memory formation and associated plasticity of neuronal function 
have been subject to intense investigation at the molecular, cellular and neuronal network 
levels, and are likely to involve all, or combination of changes in protein synthesis, gene 
expression, and cellular and anatomical structure.  
Recent years have seen an extensive search for gene regulatory mechanisms that respond 
on the short time scale associated with memory formation, while persisting over the long 
time scale over which memory can last. This has prompted a singular interest for the 
process of epigenetic inheritance. Epigenetic changes are defined as alterations in gene 
expression that are self-perpetuating in the absence of the original signal that caused them 
2,3.  The idea of persistent changes in gene expression triggered by transient events is 
intuitively parallel to the long term effects believed to be involved in memory.  
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 A major class of epigenetic mechanisms is thought to involve persistent changes in 
chromatin structure 2 (Figure 1).  Most, if not all, transcriptional regulatory events cause 
changes to chromatin structure and composition, due to the recruitment of chromatin 
modifying enzymes by transcription factors and by the transcriptional machinery itself.  
Less is known about whether, or under which circumstances, chromatin modifications 
can be stably maintained or propagated.  Nevertheless, the recent realization that most 
genes associated with mental retardation affect chromatin-remodeling processes 4,5, 
together with the identification of chromatin alterations in the process of neuronal 
plasticity and long-lasting changes in brain function, have recently brought chromatin 
biology to the forefront of molecular neuroscience and neuropathology.  A key question 
is whether the seemingly specific requirement of chromatin modifiers in neuronal 
processes merely reflects the complexity of transcriptional regulation in the nervous 
system, or indicates a special function of chromatin related mechanisms in memory and 
behavioral control. 
This essay will use representative examples in the recent literature to assess the 
contribution of various chromatin remodeling events to long-lasting changes in brain 
function. In order to investigate how, and when specific chromatin modifications impact 
brain function and behavior, the contribution of chromatin alterations to changes in brain 
function will be discussed according to their timing and duration, from the most to the 
least transient, throughout the life of the organism, and possibly across generations 
(Figure 2). 
Sustained changes in neuronal activity affect the chromatin 
Neuronal activity induces changes in gene expression that are essential to the 
establishment and maintenance of long-term neuronal plasticity in the adult brain 6. 
Consequently, and perhaps not unexpectedly, promoter regions of genes involved in 
neuronal plasticity show alterations in chromatin composition, and a growing number of 
reports have described changes in chromatin states, particularly in DNA methylation and 
histone marks, associated with long-term plasticity. 
1- DNA methylation and brain activity 
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DNA methylation of cytosine residues into 5-methyl cytosine, which in mammalian cells 
is mainly confined to CpG dinucleotides, is viewed as the most stable and long-lasting 
chromatin modification. Although the role of DNA methylation in constitutive silenceing 
of chromatin regions, X-inactivation, parental allele imprinting, retroviral and individual 
gene silencing is established, the precise mechanisms by which DNA methyl marks are 
set, maintained and erased are the topic of much debate (Box 1). The importance of DNA 
methylation in assisting essential gene regulation events associated with brain function 
and disease was revealed by the identification of Mecp2, a known methyl-CpG-binding 
domain protein (MBD) protein, as the target of mutations causing Rett syndrome 7. Rett 
syndrome is a severe X-linked mental retardation disorder characterized by late onset 
neurological defects in affected girls. Although Mecp2 is ubiquitously expressed in the 
mouse, the conditional knockout of Mecp2 in the mouse brain recapitulates the entire 
phenotype of the Mecp2-null 8,9, while rescue of expression of Mecp2 in postmitotic 
neurons prevents the emergence of phenotype in the mouse 10. Mecp2 is highly expressed 
by post-mitotic neurons, and the neurotrophin BDNF, a key player in neuronal plasticity 
events, has been identified as one of the main target genes of Mecp2 repression following 
neuronal activity 11,12. Recent analysis in mouse mutant lines that lack or over-express 
Mecp2 has pointed to additional candidate target genes of Mecp2 function in the 
hypothalamus 13. Interestingly, changes in gene expression observed in the mutant lines, 
though relatively modest, as well as demonstration of the direct binding of Mecp2 to 
promoter regions of candidate target genes, suggest a role of Mecp2 in direct activation 
as well as repression of transcription. Some of the transcriptional activation by Mecp2 
was shown to involve CREB1, a major transcriptional activator and essential component 
of signaling pathways underlying neuronal plasticity.  
The major defects in brain function and the late onset of the phenotype observed in Rett 
syndrome and related mouse models, together with cognitive impairments and defects in 
neuronal differentiation found in mutant lines for MBD1 14 suggest an important role for 
DNA-methylation marks in assisting transcriptional networks mediating normal neuronal 
homeostasis 5.  
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Yet, perturbations in gene transcription in mutants for methyl-CpG-binding domain 
proteins (MBD) such as Mecp2 are perhaps not so surprising, as the role of CpG 
methylation in gene silencing is established, although several MBD proteins appear 
dispensable for embryonic development in the mouse 15. A slightly different set of 
questions concerns the extent to which DNA methyl marks can be modified in the adult 
brain, and whether these changes can affect neuronal function. Studies along these lines 
in the nervous system are still in their infancy, and results quite controversial. In part, 
there is still major uncertainty over key mechanisms underlying the establishment and 
erasure of methyl marks in early embryonic and germ cell precursors, where robust and 
widespread changes in methylation and demethylation are known to occur (box 1). Thus, 
extreme caution should be used in interpreting data in the brain, where such changes, if 
any, may be rather modest and affect only a few genes. 
Both maintenance and de novo DNA methyltransferases DNMT1, and DNMT3a 
respectively, are found expressed at high levels in the developing and adult nervous 
system 16. The expression of these enzymes in post-mitotic neurons is rather intriguing 
but does not necessarily imply a function in active methylation in these cells, as de novo 
and maintenance methylation in germ cell development and embryogenesis occurs during 
DNA replication. Further, injection of DNMT inhibitors reportedly leads to defect in 
memory-associated neuronal plasticity. However, the requirement of DNA synthesis for 
the activity of the drugs, together with the toxicity and lack of specificity of the inhibitors 
employed make the interpretation of the results difficult 16. CNS-specific conditional 
DNMT knockouts affecting DNA methylation in dividing neuronal precursors lead to 
profound neuronal defects, suggesting a role of DNA methylation in neuronal 
development. These results, however, provide little information about changes in DNA 
methylation in postmitotic neurons. 
Surprisingly, a recent report described a significant, though rather modest reduction in 
DNA methylation at specific promoter regions of BDNF and FGF1 in the adult dentate 
gyrus of the mouse following electroconvulsive treatment 17. Through loss of function 
experiments, the authors invoked the participation of Gadd45b (growth arrest and DNA 
damage-inducible protein 45 beta) in this phenomenon, a member of a family of 
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molecules that has been shown in some systems, though refuted in others, to act as 
cofactors promoting DNA demethylation through DNA repair 18,19,20,21. The functional 
impact on gene transcription of rather weak incremental reductions rather than genuine 
loss of promoter methylation is unclear. Further, as the precise mechanistic links between 
Gadd45 activation, DNA demethylation and DNA repair remain to be clarified (Box 1), 
the simple interpretation of these results as an indication that active DNA demethylation 
is detected in postmitotic neurons will await further supporting evidence.  
As will be detailed in a later part of this review, the methylation status of a number of 
genes involved in behavioral control has similarly been reported to vary according to 
early postnatal environmental conditions, raising particularly intriguing questions about 
the ability of the environment to affect the DNA methylation status of neural genes. 
Interestingly, 5-hydroxymethyl-2′-deoxycytidine (hmdC) was recently identified as an 
abundant nucleotide in many regions of the adult brain, including the cortex, brain stem 
and in cerebellar Purkinje neurons 22. This is an intriguing discovery, as hmdC may 
represent an intermediate for oxidative demethylation, or an end product that could 
modulate the binding of proteins that normally recognize 5-methyl cytosine. 
2- Histone modification and neuronal plasticity 
Molecular analysis of signaling pathways underlying neuronal plasticity has identified 
alterations of histone marks, particularly histone acetylation, in transcriptional units 
induced by neuronal activity, and has implicated histone modifying enzymatic complexes 
in memory formation (see background information on histone modifications in Box 2). 
These findings have raised interesting mechanistic questions, as well as new ideas for the 
design of drugs aimed at memory impairment.  
Sensory experience and resulting neuronal activation leads to depolarization and calcium 
influx into the postsynaptic cell, which in turn triggers signals orchestrating short- and 
long-term changes in synaptic strength. The induction of specific activity-dependant 
transcriptional programs has been shown to play a key role in experience-dependent long-
term neural plasticity 6. In depth studies have led to the characterization of a prototypical 
signaling pathway that is evolutionally conserved in Aplysia, Drosophila, and mouse, and 
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by which extracellular stimuli are transformed into changes in activity-dependent gene 
expression 23. Gene regulation by the cyclic AMP response element binding protein 
(CREB), originally identified as binding to the cAMP- and Ca-dependent response 
elements of the somatostatin and cfos genes, respectively, as well as mediating long term 
synaptic potentiation in Aplysia 24, is particularly central to the expression of many forms 
of long-term memory. Following postsynaptic depolarization and Ca entry, activated 
CREB binds to the cAMP response element (CRE) in the promoter region of activity-
induced genes such as the immediate early gene cfos, and the neurotrophin BDNF, and, 
in conjunction with different combinations of other factors 23 orchestrates long term 
activity-induced changes in gene expression.  
Changes in histone post-translational modifications in general, and in histone acetylation 
in particular, have been extensively documented at promoters of genes induced by 
sustained neuronal activity. For example repeated electroconvulsive treatment, which 
induces long-term changes in neuronal activity that are beneficial for treatment of 
depression, triggers histone modifications at promoters of genes such as CREB, BDNF, 
c-fos that display sustained changes in transcription, but not at neuronal genes with 
unchanged expression 25. Similarly, an increasingly large number of paradigms have 
documented alterations in histone post-translational modifications in activity-dependent 
neuronal plasticity, addiction and long-term memory formation 6,26,27,28,29. Furthermore, 
pharmacological alteration of histone deacetylase (HDAC) activity significantly affects 
the process of memory formation, although the poor specificity of currently available 
reagents clearly limits the interpretation of the results 30,31,32. 
At the mechanistic level, CREB-associated transcriptional regulation has been shown to 
involve the recruitment of multi-component regulator complexes as well as the initiation 
of chromatin remodeling events. Activated CREB recruits CREB-binding protein (CBP), 
or its paralog p300, which functions both as a scaffolding protein and a histone 
acetyltransferase (HAT) 6. CBP recruitment in turn stimulates histone acetylation and 
transcriptional complex formation at the promoters, leading to transcriptional activation 
of many CREB-target genes. Mutations in the CBP/p300 gene are responsible for the 
mental retardation syndrome Rubinstein–Taybi 33 the phenotype of which may result 
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from impairment in either or both of CREB-dependent and -independent functions of 
CBP. The essential role of HAT activity in CBP-mediated neuronal plasticity has been 
genetically demonstrated by the selective long-term memory defects of a transgenic 
mouse line carrying a dominant negative CBP that blocks the HAT activity of the 
endogenous protein 34.  
Similarly, histone deacetylase (HDAC) activity has been associated with repression of 
neuronal activity-dependant gene transcription. HDAC2 has recently been identified by 
chromatin immunoprecipitation (ChIP) at the promoter regions of a large number of 
genes involved in synaptic plasticity or activity-dependent processes, such as Bdnf, Egr1, 
Fos, Cpg15, Camk2a, Creb1, Crebbp, NRXN3 and the NMDA receptor subunits, and 
appears to associate with known neuronal transcriptional co-repressors such as mSin3, 
MTA2 and CoREST 31. This has led to the suggestion that a balance between histone 
acetylation, leading to transcriptional activation, and histone de-acetylation with 
subsequent gene repression is as an essential component of the long-term regulation of 
activity-dependent genes in the brain. 
The study of genetically modified mouse strains, in which the function of specific 
histone-modifying enzymes has been altered in the brain has further revealed the 
fundamental contribution of chromatin remodeling to long-term neuronal plasticity and 
addiction. Cocaine induces HDAC5 phosphorylation and nuclear export in the Nucleus 
Accumbens (NuAc), and viral and genetic manipulations of HDAC5 expression in the 
NuAc significantly alter the response to chronic, but not acute cocaine and stress 
exposure 29. In another study, overexpression of HDAC2 but not HDAC1 leads to 
impairment in synapse formation and plasticity and in hippocampus-dependent long term, 
but not short-term memory formation, while conditional neuron-specific HDAC2 
knockout leads to increased synapse formation and memory facilitation 31.  
 
Postnatal, forebrain-specific deficiency of the histone methyltransferase complex 
GLP/G9 leads to a drastic reduction in neuronal euchromatic H3K9me2 levels 35. 
Genetically modified animals display complex behavioral abnormalities, including 
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defects in learning, motivation, and environmental adaptation but no apparent structural 
abnormality. Importantly the behavioral phenotypes are distinct from those found in mice 
with forebrain ablation of another histone lysine methyltransferase, Ezh2 which is 
essential for H3K27 methylation, and has been shown to play an important role in lineage 
specification and neuronal and astrocyte differentiation 36,37. Interestingly upregulation of 
neuronal progenitor and non-neuronal genes was identified in GLP/G9 deficient mice, 
suggesting an essential role of GLP/G9 in maintaining neuron-specific transcriptional 
homeostasis and in protecting adult neurons from expression of non-neuronal and 
neuronal progenitor genes. 
In another recent study, repeated cocaine administration was shown to induce repression 
of G9a and H3K9me2 and to promote cocaine preference, in part through the 
transcriptional activation of numerous genes known to regulate aberrant forms of 
dendritic plasticity. Thus H3K9 dimethylation appears essential to ensure the stability of 
proper neuronal gene expression programs 38. 
 
3. Debating the role of histone modifications in plasticity 
The studies reported here document a fascinating new side of the control of neuronal 
plasticity. However, one must exercise extreme caution in interpreting the role of histone 
modifications in this process, as histone marks are an extension and reflection of the 
underlying transcriptional network, and cannot therefore be interpreted alone (Box 2). 
The highly transient nature of histone marks must also be kept in mind. Histone 
acetylation for example was shown in some experimental systems to display a half-life in 
the order of minutes 39. Similarly a histone methyl mark such as H3K4me3, although 
more stable, has been shown in yeast not to be maintained after removal of the gene 
activating stimulus, even a loci known to be subject to epigenetic regulation 40. In a study 
looking at neuronal differentiation in vitro 41 H3K27me3 marks associated with 
polycomb-mediated repression emerge in progenitor cells as in anticipation of neuronal 
differentiation, but not in embryonic stem cells despite the fact that the corresponding 
genes are silenced in these cells as well. Thus, the histone mark does not indicate 
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silencing in absolute term, but instead the ability for dynamic regulation and recruitment 
of sequence- and context- specific transcription factors. These illuminating studies in 
simpler experimental systems emphasize the need for more detailed mechanistic studies 
of transcriptional events related to neuronal plasticity. 
What is the adult brain inheriting from the neonatal epigenome? 
The origin of behavioral diversity within individuals of a given species constitutes one of 
the most fundamental questions in behavioral neuroscience, and decades of research has 
tried to determine the respective roles of genetic and early environmental influences in 
shaping adult behavioral patterns. The term of epigenetics is increasingly invoked to 
interpret studies from rodents to non-human primates and humans, in which stochastic 
developmental events and environmental information appear to stably sculpt 
physiological, behavioral traits and disease susceptibility from the early perinatal period 
into adulthood. 
Studies of human monozygotic twins raised together, compared to monozygotic twins 
raised apart reveal significant discordance in behavioral and physiological phenotypes as 
well as in disease susceptibility that cannot be accounted for by simple Mendelian 
inheritance of genetic traits, nor by identifiable environmental differences 42. These 
results have been confirmed by analysis of genetically identical inbred rodents and cattle 
raised in tightly controlled versus variable pre- and postnatal environments 43, and more 
recently by observation of cloned animals 44. This paradox led to the early hypothesis of a 
“third component …. effective at or before fertilization” 43, the basis of which was 
proposed by some authors to rest in differential and heritable chromatin remodeling 
events that occur during cell differentiation and embryonic morphogenesis 42. Consistent 
with this hypothesis is the example of monozygotic twins discordant for Beckwith–
Wiedemann syndrome (BWS) 45, which is thought to result from unequal distribution 
among twins of DNA methylation enzymes in the inner mass stage, leading to a defect in 
maintenance of imprinting at KCNQ1OT1. However, variability in chromatin 
modifications cannot be interpreted in abstract, outside the context of specific gene 
transcriptional regulation. Sophisticated analyses of stochastic variation in eukaryotic 
gene expression, from yeast to metazoans, suggest that fluctuation in chromatin-mediated 
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events may indeed participate in gene expression variability, and that the range of 
variability is tightly linked to the degree of connectivity of genes within a transcriptional 
network, such that highly interconnected developmental networks are better able to buffer 
stochastic variability 46,47. 
Thus, a certain range of stochastic variability in the epigenetic inheritance of neuronal 
progenitors may underlie stable differences in brain function, behavior and neurological 
disease susceptibility among individuals sharing similar genomes and environmental 
conditions. However the precise mechanisms involved are far from being elucidated, and 
in depth studies of stochastic variability during brain development, such as those 
performed in simpler experimental systems, are lacking. 
 
Perhaps even more striking than a rather limited stochastic variability, are published 
reports suggesting that the early perinatal environment may actively and durably shape 
the neural, behavioral, and pathological state of individuals.  Examples in the literature 
are numerous, affecting both neural and non-neural functions, and although the 
underlying mechanisms are still largely undefined, the influence of the environment on 
the chromatin configuration of certain genes has been put forward as a leading hypothesis 
for these stable changes.  
The ability of the pre- and early post-natal environment in establishing distinct behavioral 
traits among genetically identical animals was directly demonstrated by combining 
embryo transfer and cross-fostering among the two inbred mouse strains C57BL/6J and 
BALB/cj 48. Differences between the C57BL/6J and BALB/cj strains have been well 
documented in exploratory and anxiety-related behaviors, watermaze performance and 
sensory motor gating, and were widely assumed to result from genetic factors. 
Surprisingly, C57BL/6J mice developing in a BALB/cj uterus and reared by a BALB/cj 
mother showed 3 out of 4 tested behaviors identical to that of BALB/cj mice and 
significantly different from other C57BL/6J. Thus a combination of pre- and early post-
natal maternal environment is able to significantly shape the development of adult 
behavior. 
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In studies with far reaching impact on human health, worldwide epidemiological analyses 
in humans as well as direct experimentation in animal models indicate that defects in 
maternal and early postnatal nutrition influence a number of health risks factors in adult 
life, mainly cardiovascular and metabolic diseases such as hypertension, insulin 
resistance and obesity, a phenomenon commonly named metabolic syndrome 49. 
Nutritional deficiency, and restriction or excess in the maternal and post-natal diet during 
critical developmental time-windows results in permanent alterations in the adult function 
of peripheral organs, such as the liver, kidney, heart, adipocyte, and of the hypothalamo-
pituitary-adrenal (HPA) axis. In addition to a direct perturbation of developmental events 
underlying organogenesis, the influence of early nutrition on the establishment and 
maintenance of cytosine methylation, including the methylation of retrotransposons 50,51 
and of imprinted genes 52 points to chromatin remodeling as a potential target of early 
environmental influence. 
More generally, the HPA axis and the organization of peripheral and central stress 
responses have emerged as a main target of long-lasting perinatal environmental 
influences. Seminal work with rodent neonates showed that manipulations of the mother–
infant relationship have long-term consequences on neuroendocrine and behavioral 
responses later in life, and that maternal handling exerts a strong inhibitory effect on the 
HPA function of adult offspring, resulting in lower stress and fear responses 53,54. A series 
of recent studies from rodents to non-human primates and humans have investigated the 
molecular mechanisms by which maternal-infant relationship may exert such lasting 
changes on HPA function.  
In the rat, variation in the amount of maternal grooming, licking and associated 
somatosensory stimulation of the pups lead to differences in fear responses and HPA 
function of the adult offspring. In a remarkable non-genetic transmission of behavior 
traits, daughters raised or cross-fostered by poorly grooming mothers, become highly 
fearful and stressed adults, and in turn are poorly grooming dams 55. A signaling pathway 
linking maternal care to the stress response of the offspring has been proposed. High 
maternal somatosensory stimulation increases 5HT signaling in the hippocampus of the 
pups, and activates a cAMP-dependant protein kinase signaling pathway, which in turn 
leads to increase in the expression of the transcription factor nerve growth factor induced 
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protein A (NGFI-A). NGFI-A binds to and regulates the activation of the exon 17 
promoter of the glucocorticoid receptor (GR) promoter, leading to increase in 
transcription of specific isoforms of the GR. High level of GR expression in offspring of 
high grooming moms is stably maintained into adulthood, well after maternal stimulation 
has ceased, suggesting a mechanism to permanently increase GR transcription. 
Interestingly, differences in GR expression between the offspring of high- and low-
grooming females correlate with differential levels of DNA methylation and histone 
acetylation at the exon 17 GR promoter that display NGFI-A recognition sites, resulting 
in alterations in NGFI-A binding 56. Low DNA methylation, high histone acetylation of 
exon 17, and resulting high NGFI-A binding and GR expression correlated with high 
level of maternal care are established within the first week of postnatal life, and 
maintained in the adult. Notwithstanding the caveats related to the low target specificity 
of the drug, and its rather indirect effect, brain infusion of the adult offspring with the 
HDAC inhibitor trichostatin A (TSA) is reported to eliminate the maternal effect on GR 
expression 56. In another report of the effect of early life stress on chromatin remodeling 
of genes with important behavioral functions, mild though significant hypomethylation of 
the arginine vasopressin (AVP) promoter was recently described in the mouse 
hypothalamus following experimental mom-infant separation 57.  
These still highly correlative data have led to the suggestion of a mechanistic link 
between life-long changes in behavioral traits, and the establishment of chromatin 
modifications of key genes in a critical perinatal period. Identifying a clear causal 
mechanistic relationship between these events will require an in depth understanding of 
the players and mechanisms involved: What are the neuronal types involved across the 
brain? What broader changes may be taking place in chromatin and in transcriptional 
networks? In a system as complex as the brain and underlying behavioral circuits, 
obtaining specific genetic and pharmacological tools will significantly enhance the ability 
to answer these questions. Chromatin remodeling is only one part of a larger puzzle of 
how behavioral traits are generated and maintained, and the rather modest changes in 
methylation levels observed in only a few genes seem unlikely to underlie such profound 
behavioral differences across the population. Other mechanisms proposed to mediate 
stable behavioral differences are equally attractive. The maternal-infant relationship in 
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non-human primates for example has been shown to affect brain function through 
neurotrophin action 58, which may or may not include any chromatin related events. 
 
The influence of mom and dad on the brain of offspring 
Genomic imprinting 
Genomic imprinting is a set of epigenetic modifications unique to placental mammals and 
flowering plants that is established in the parental germ lines and somatically maintained, 
and that results in the preferential expression of the maternal or the paternal allele of 
certain genes. The monoallelic expression makes these loci especially vulnerable to 
mutations and deregulation, and they often contribute to diseases and disorders 59. The 
evolutionary pressures that lead to imprinting of specific loci are matters of great debate 
60,61,62. The first imprinted genes discovered: Igf2 63 and Igf2r 64 are paternally and 
maternally expressed, respectively, and have opposing effects on embryonic growth.  
Since these landmark papers, the vast majority of imprinting studies have focused on 
embryonic growth and development 65,66. In rodents and humans, nearly 100 imprinted 
genes have been identified, which are often organized in clusters in the genome. A 
bioinformatic approach estimated the existence of 600 imprinted genes in the mouse 
genome 67, although this study failed to predict any imprinted genes on the X-
chromosome, which are now known to exist 68,69.  
Strikingly, many imprinted genes have been found to be expressed in the brain, where 
they serve unknown functions, and genetic analysis in mice has identified behavioral and 
neurological function as the second most frequent function affected in mouse mutants for 
imprinted genes, right behind embryonic growth 70. A handful of studies have 
demonstrated roles for some imprinted genes in the regulation of homeostatic brain 
functions such as thermoregulation, maintenance of circadian rhythm, feeding behavior, 
as well as maternal and mating behaviors 70.  Further, it has been proposed that imprinted 
genes regulate a broad spectrum of social behaviors, including mother-infant bonding, 
kin recognition, risk taking behavior, the sharing of resources within social groups, and 
sexually dimorphic behaviors 70 Clinical studies of patients with neurological disorders 
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related to imprinting, such as Angelman Syndrome, Prader-Willi Syndrome and Turner 
Syndrome, have also demonstrated clear roles for imprinted genes in the regulation of 
human social behaviors 71.  
 
Work on imprinted loci demonstrates that the imprinting status of some genes can be both 
temporally and spatially regulated. These data on only a small number genes so far 
provide additional complexity to the long held view that imprinting is stably established 
in parental gametes and early embryonic stages, and suggest instead that mechanisms 
may exist throughout adulthood to dynamically modulate the outcome of parental 
chromatin marks. Interestingly, as parental marks are established in primordial germ cells 
of offspring’s, environmental factors in the prenatal maternal environment will affect 
genomic imprinting of F2s (Figure 2). 
 
Trans-generational inheritance  
As shown in many of the examples cited in this review, a growing body of evidence 
indicates that the chromatin state can be influenced by environmental conditions. This, in 
turn, opens the door for a mechanistic underpinning of the so-called “soft inheritance” 
according to which specific environmental conditions may lead to a non-Mendelian 
transgenerational inheritance of certain traits, a phenomenon widely reported in plants, 
and increasingly discussed in animals as well 72. For example in utero alterations of DNA 
methylation affecting F1s and F2s have been reported as a result of a maternal diet that 
affects single carbon metabolism, or that contains endocrine disrupting compounds 
72,73,74,75. Although no direct evidence yet links imprinting, perturbed chromatin states and 
nutritional environment changes, the hypothesis that imprinted genes may play a role in 
the trans-generational effects of the maternal diet on the physiology of offspring has 
increasingly been suggested 73. More generally, environmental effects on genomic 
imprinting during pregnancy appears as an attractive mechanism to explain trans-
generational effects, which in mammals has yet to be observed beyond F2s 72,76 
 
Outlook on chromatin remodeling processes in the adult brain 
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The increasingly large number of experimental data associating long-term changes in 
brain activity with alterations in chromatin raises several fundamental questions. Histone 
posttranslational modifications and other chromatin remodeling events are expected 
mechanisms of gene regulation in any cellular system undergoing long-lasting changes. 
Nothing unique to the brain in the chromatin remodeling events has been reported so far, 
and it is unclear that these provide anything but a transient contribution to the underlying 
transcriptional network that may not be sustained in the absence of the network itself. 
Finally, the predictive value of the observed changes, a “code” of modification associated 
with specific changes in brain activity that in turn may be exploited for further 
experimental or clinical intervention is far from established. 
Chromatin remodeling events described so far in the context of long-term changes in 
brain function are merely part of a larger and much more complex transcriptional control 
pathway. The level of mechanistic detail achieved in understanding chromatin 
remodeling within the context of transcriptional control in simpler or reconstituted 
experimental systems 77 is far from being reached in the nervous system. Only a few 
histone PTMs or other chromatin remodeling events have so far been investigated. 
Moreover, little mechanistic insight has been gained to date, that may underlie the 
reported specificity of chromatin remodeling events to the subsets of genes affected by 
neuronal activity. The interesting examples of ncRNA-mediated targeted DNA 
methylation identified in plants 78, the transcriptional silencing of distant  chromosome 
domains by long non-coding RNAs 79 represent new mechanisms providing specificity to 
chromatin remodeling events that may be worth investigating in the context of the brain 
development and function. Finally, chromatin remodeling events are not intrinsically long 
lasting, and in fact, with perhaps the exception of Polycomb group proteins 80, the 
inheritance of chromatin marks through DNA replication is still an open question. Thus, 
chromatin components, as well as the associated transcriptional regulatory machinery 
may be required to determine the stability or dynamic state of chromatin changes. 
 
 
A complicating and often neglected factor in the interpretation of histone modifications in 
neuronal plasticity results from the fact that what so-called “histone-modifying enzymes” 
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play in fact other roles in the cell beyond histone modifications, such as scaffolding and 
modifying non-histone substrates. The Elongator complex, for example, plays an 
essential role in the migration and differentiation of cortical neurons 81. Although 
Elongator is a known histone H3 acetylase in the nucleus, it also targets cytoplasmic 
proteins such as a-tubulin and other unknown substrates. The reduction of a-tubulin 
acetylation via expression of a nonacetylatable a-tubulin mutant leads to defects in 
neuronal branching of cortical neurons that are similar to mutations in the acetylation 
subunit of Elongator, demonstrating that a-tubulin is in fact the key target of this 
complex. Moreover, Elongator acetylation of a-tubulin in vitro is counteracted by 
HDAC6-mediated deacetylation, illustrating a delicate balance in acetylation-
deacetylation of substrates distinct from histones in the process of neuronal maturation. 
In another study, HDAC6, in addition to its well-described histone-modifying activity, 
was shown to biochemically and functionally interact with Cdc20 and to stimulates 
Cdc20-APC activity through polyubiquitination 82 in a process essential to dendrite 
morphogenesis in post-mitotic neurons. 
In conclusion, despite the clear involvement of chromatin modifications demonstrated in 
many paradigms of long term changes in brain function, the relative lack of mechanistic 
insights beyond correlative observations with a handful of changes such as few of the 
known histone PTMs, does not yet permit one to draw a precise picture of the impact of 
chromatin remodeling on changes in neuronal activity. The transcriptional machinery 
itself is not invariant, and in addition to specific transcription factors, core components of 
the transcription machinery could also vary among different cell types. For example, 
during skeletal myogenesis, cells no longer use the canonical TFIID complex but instead 
use a specialized complex, generating a customized pre-initiation machinery for this cell 
type 83. Similarly, different effectors may interact with different chromatin marks 
according to the biological context. Clearly, the complexity in histone PTMs and 
chromatin remodeling has not yet been approached in the context of neuronal function, 
and genetic dissection of essential substrates and enzymes, together with precise 
reconstitution experiments will be critical to gain insights into the chromatin machinery 
that orchestrates stable changes in brain processes.  
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BOX 1: DNA methylation and demethylation 
The DNA can be covalently modified by methylation of the cytosine residue into 5-
methyl cytosine, which in mammalian cells is mainly confined to CpG dinucleotides. The 
presence of another methyl cytosine modification, 5-hydroxymethyl-2′-deoxycytidine 
(hmdC) was recently reported in the adult mouse brain 22, and its functional significance 
is yet to be determined.  
CpG methylation has been involved in X-inactivation, genomic imprinting, suppression 
of transposable elements, and is required for proper embryonic development. The 
locations of CpG-rich regions of the genome, also called CpG islands, are often 
correlated with gene promoter regions, and changes in the methylation status of key 
developmental genes has been proposed to participate in restriction of pluripotency and 
lineage commitment. The role and mechanisms of DNA methylation in ensuring tissue-
specific gene expression are not entirely clear. Moreover, the extent and underlying 
mechanisms of changes in methyl marks are highly debated questions that are of 
particular relevance for the study of long lasting transcriptional changes in the brain.  
To directly visualize changes in methylation marks associated with the establishment of 
lineage- and pluripotency-specific transcriptional programs, large scale and genome-wide 
analysis of DNA methylation has been recently performed, documenting differences in 
patterns of methylation according to the developmental stage or cell type analyzed 
84,85,86,87. Surprisingly, significant differences were also uncovered in gene regions outside 
CpG islands, and for ES cell outside of CG context, underscoring the still poorly 
understood complexity of transcriptional control in promoter regions as well as gene-
bodies. Widespread differences in composition and pattern of cytosine methylation were 
observed in different cell types 85,86, although the number of promoters that display either 
loss or gain of methylation between ES cells and terminally differentiated neurons 
appears rather modest 41 
Microarray analysis of the methylation status of 15,000 promoters in ES cells and 
terminally differentiated pyramidal neurons in vitro reported a gain of DNA methylation 
on only 343 (2.3%), and an even less frequent loss of DNA methylation, on 22 (0.1%) of 
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the tested promoters during neuronal differentiation. Strikingly, analysis at an 
intermediate developmental stage, that of neuronal progenitors, shows that most changes 
occur at the transition from ES cells to progenitor state, suggesting that alterations in 
DNA methylation correlate more strongly with fate commitment and loss of pluripotency, 
rather than with terminal neuronal differentiation 41. Interestingly, many promoters 
bearing the Polycomb-mediated histone H3 methylation (H3K27me3) in ESCs acquired 
DNA methyl marks during differentation, suggesting interrelated processes. 
The mechanisms by which differential methylation patterns are established in mammals 
remain highly debated. While enzymes carrying DNA methylation are shared between 
plants and mammals, and their mechanisms of action well understood 88, a lot of 
uncertainty is left regarding mechanisms of DNA de-methylation 89. DNA demethylation 
can result from passive demethylation in absence of maintenance methylation following 
DNA replication, or from an active process of enzymatic removal of the 5-
methylcytosine mark. Active genome-wide demethylation are thought to occur at two 
times of development (figure 2), in the male pronucleus of the zygote, right after 
fertilization, and in primordial germ cells of E11.5-12.5 embryos. Unfortunately none of 
the plant enzymes involved in the active process appear conserved in mammals, and there 
is still some debate as to how these events occur. The DNMTs, which are expressed in 
both fetal and adult tissues may be involved, while other studies, including in the adult 
brain, have proposed a very different mechanism in which 5-methylcytosine is removed 
from DNA in a deamination and base excision/repair process 17,18,21,90,91,92. Two recent 
reports in mouse primordial germ cells and somatic cells induced to pluripotency have 
given additional credence to the deamination-repair dependent DNA demethylation 
process 93,94. How more targeted promoter demethylation process may occur is unknown, 
although some reports have shown interesting switch of DNA methylation and 
demethylation in hormone-induced transcriptional control 82. 
 
BOX 2- Histone modifications 
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Histones, particularly H3 and H4, are subject to extensive covalent post-translational 
modifications (PTM) that include methylation, acetylation, phosphorylation, 
ubiquitination, sumoylation, biotinylation, ADP-ribosylation, and likely more to be 
discovered, each occurring at specific sites and residues 95. Some histone modifications 
act in cis to directly alter the local chromatin structure, while others act in trans to 
influence the recruitment of chromatin-modifying factors. In trans, histone modifications 
enable specific binding partners to dock, often as part of larger multi-molecular 
complexes that generate further chromatin remodeling. Acetylated histone residues are 
recognized by bromodomains, often associated with histone acetyltransferases (HAT), 
thus leading to spread of the histone modification. Similarly methylated lysine residues 
are recognized by chromodomain- containing proteins. This recognition is highly 
dependent on the chromatin context, such that a given chromodomain- or bromodomain- 
containing protein may only bind to a given set of methylated, or acetylated histone 
residues, respectively, and only in the presence of other defined chromatin effectors 96. 
Histone modifications do not occur in isolation, but often as combinations of marks. The 
understanding of the regulation and physiologically relevant substrate specificity of these 
enzyme complexes remains a challenge. Moreover, many histone-modifying enzymes 
also target non-histone substrates, underscoring the complexity of chromatin dynamic 
and associated cellular processes.  
Concerted efforts have been made to establish clear functional links between histone 
modifications and changes in transcriptional activity, leading to the enticing and highly 
debated hypothesis of a “histone code” with predictive value on the transcriptional status 
of genes 97,98. For example silenced chromatin typically displays low levels of histone 
acetylation, together with high levels of H4K20me3 and H3K27me3, while 
hyperacetylation, H3K4me3 and H3K36me3 are recognizable marks of active 
transcription. Faced with the ever growing number and complexity of chromatin 
modifications within a given transcriptional unit, it is however becoming clear that a 
single histone mark, or defined combination of, are not be simply predictive of a given 
transcriptional outcome: H3K9me2/3 and H3K4me2/3 for example are found enriched on 
silenced and actively transcribed genes, respectively, but are also present in the reciprocal 
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state 99. The possible combinatorial effect of multiple histone modifications has recently 
been addressed by a genome-wide analysis of PTMs occurring on single nucleosomes in 
correlation with transcription levels 96,100. The data largely confirm known bias towards 
certain combination of histone marks at promoters, transcription sites, gene bodies and 5’ 
and 3’ UTRs, which had previously been associated with active or repressive chromatin 
states. However, discrete PTM combinations rarely appear repeated within the genome, 
with most patterns detected on single promoters. Thus, instead of revealing a simple 
predictive “code” shared by many genes, in depth observation of histone modification 
patterns highlights instead the unique complexity of each transcriptional unit and 
associated transcriptional regulatory machinery to ensuring proper response to cellular 
signals. 
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Figure 1: Mechanisms involved in chromatin modifications 
Five broad and interrelated mechanisms are known to affect chromatin structure: DNA 
methylation, histone modification, insertion of histone variants, remodeling complexes, 
and non-coding RNAs.  All five have been shown to be essential contributors to the 
development and cell fate determination of tissues including in the nervous system, while 
histone modifications and DNA methylation have so far been more extensively 
investigated in the context of adult brain function. 
 
 
Figure 2: Contribution of various chromatin remodeling events throughout life of 
an organism. 
Chromatin modifications occurring at different time points during the life of an organism 
have been associated with various short to long-lasting regulatory events that affect the 
development and the function of the brain and other tissues. 
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